| LncRNA |
Compound |
Cancer |
P-value |
Effect |
| ENSG00000257702.3 |
Ponatinib |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
0.03738553 |
Resistant |
| ENSG00000257702.3 |
Ponatinib |
Breast invasive carcinoma |
0.048224557 |
Sensitive |
| ENSG00000257702.3 |
Ponatinib |
Esophageal cancer |
0.024856844 |
Resistant |
